MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 4351-4360 Newer>
The Motley Fool
November 9, 2004
Alyce Lomax
Does Pacific Sunwear Shine? The surf, skate, and hip-hop retailer posts a decent quarter. But investors considering this company may want to hold tight and watch the numbers. mark for My Articles 133 similar articles
The Motley Fool
November 9, 2004
Brian Gorman
Cocoa Crisis? Unrest in the Ivory Coast could mean trouble for companies that need chocolate. For investors, that means it pays to keep track of events around the world. mark for My Articles 37 similar articles
The Motley Fool
November 9, 2004
Tom Taulli
Novell's Strong Suit? Novell has spent years battling Microsoft. Maybe this time it will work. Their stock surged 9.48% to $7.51. mark for My Articles 862 similar articles
The Motley Fool
November 9, 2004
Charly Travers
Genta's on the Ropes Aventis' exit leaves the pharmaceutical company in dire straits. Genta's stock opened down 40% this morning and is now down 85% for the year. mark for My Articles 11 similar articles
The Motley Fool
November 9, 2004
Seth Jayson
Buy This Bear? Build a Bear Workshop is exactly the kind of concept that could make it a rapidly growing rule breaker. It isn't exactly bargain-priced, but there's plenty of room for the experienced management to overdeliver. mark for My Articles 109 similar articles
The Motley Fool
November 9, 2004
Dave Mock
Can Jamdat Survive the Hype? Earnings from hot new issue Jamdat Mobile don't live up to analysts' expectations. The stock dropped more than 20% following the release in after-hours trading. mark for My Articles 45 similar articles
The Motley Fool
November 9, 2004
Rich Smith
Eyeing Laser Care Profits Eye care specialist TLC draws eyes to the field of high-tech vision correction. The company swung to a $0.05-per-diluted-share profit against its year-ago $0.06 loss. mark for My Articles 27 similar articles
The Motley Fool
November 9, 2004
Charly Travers
Are Stem Cells a Rule Breaker? Does the science offer real hope or just hype? Biotech investors take on enough risk in the normal course of drug development that they do not need to worry about whether or not the underlying technology even works. mark for My Articles 861 similar articles
The Motley Fool
November 9, 2004
Rick Aristotle Munarriz
Thrill Rides: Ups and Downs There are six reasons to get excited about Six Flags next year. Tuck in a handkerchief so you can loan it out to the teary-eyed investor who missed out on buying into Six Flags while it was still unloved. mark for My Articles 181 similar articles
The Motley Fool
November 9, 2004
Selena Maranjian
Online Trading Tips Learn how to trade online -- and then don't be afraid to do so. mark for My Articles 228 similar articles
<Older 4351-4360 Newer>    Return to current articles.